SMid Cap Biotech Analyst Rama holds a conference call with CEO Hata on March 25 at 11:30 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDYA:
- Ideaya Biosciences price target raised to $60 from $40 at Citi
- Ideaya enters supply agreement with Merck to evaluate IDE161, Keytruda
- GE upgraded, Vail Resorts downgraded: Wall Street’s top analyst calls
- Ideaya Biosciences initiated with a Buy at BTIG
- Ideaya Biosciences price target raised to $53 from $43 at RBC Capital